Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla-C Dubinsky

Showing results (101-110 of 247) with videos related to

Pageof 25
Sort By:
Inflammatory Bowel Diseases|August 3, 2016
Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care UseLaura C Reigada, Ankita Satpute, Claire J Hoogendoorn, et al.
Inflammatory Bowel Diseases|August 20, 2016
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel DiseaseNamita Singh, Shervin Rabizadeh, Jacqueline Jossen, et al.
Clinics and Research in Hepatology and Gastroenterology|May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel diseaseSeverine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases|December 11, 2008
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL surveyDavid T Rubin, Corey A Siegel, Sunanda V Kane, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 6, 2011
Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patientsAdrienne Lee, Tanya A Griffiths, Rohan S Parab, et al.
Inflammatory Bowel Diseases|February 10, 2026
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory DisordersVirginia Solitano, Laurent Peyrin-Biroulet, Severine Vermeire, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 29, 2019
De Novo Crohn's Disease of the Pouch in Children Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative ColitisLauren Jarchin, Elizabeth A Spencer, Sergey Khaitov, et al.
Inflammatory Bowel Diseases|August 15, 2020
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction StudiesMarla C Dubinsky, Marco DiBonaventura, Haiyun Fan, et al.
Patient Related Outcome Measures|December 30, 2022
Exploring Disease Remission and Bowel Urgency Severity Among Adults with Moderate to Severe Ulcerative Colitis: A Qualitative StudyMarla C Dubinsky, Louise Newton, Laure Delbecque, et al.
Gastroenterology|March 23, 2002
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel diseaseMarla C Dubinsky, Huiying Yang, Philip V Hassard, et al.
Pageof 25

Showing results (101-110 of 247) with videos related to

Sort By:
Pageof 25
Inflammatory Bowel Diseases|August 3, 2016
Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care UseLaura C Reigada, Ankita Satpute, Claire J Hoogendoorn, et al.
Inflammatory Bowel Diseases|August 20, 2016
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel DiseaseNamita Singh, Shervin Rabizadeh, Jacqueline Jossen, et al.
Clinics and Research in Hepatology and Gastroenterology|May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel diseaseSeverine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases|December 11, 2008
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL surveyDavid T Rubin, Corey A Siegel, Sunanda V Kane, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 6, 2011
Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patientsAdrienne Lee, Tanya A Griffiths, Rohan S Parab, et al.
Inflammatory Bowel Diseases|February 10, 2026
Immunometabolism as a New Bimodal Therapeutic Concept in Inflammatory Bowel Disease and Immune-Mediated Inflammatory DisordersVirginia Solitano, Laurent Peyrin-Biroulet, Severine Vermeire, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 29, 2019
De Novo Crohn's Disease of the Pouch in Children Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative ColitisLauren Jarchin, Elizabeth A Spencer, Sergey Khaitov, et al.
Inflammatory Bowel Diseases|August 15, 2020
Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction StudiesMarla C Dubinsky, Marco DiBonaventura, Haiyun Fan, et al.
Patient Related Outcome Measures|December 30, 2022
Exploring Disease Remission and Bowel Urgency Severity Among Adults with Moderate to Severe Ulcerative Colitis: A Qualitative StudyMarla C Dubinsky, Louise Newton, Laure Delbecque, et al.
Gastroenterology|March 23, 2002
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel diseaseMarla C Dubinsky, Huiying Yang, Philip V Hassard, et al.
Pageof 25